Protection of cotton rats against human parainfluenza virus type 3 by vaccination with a chimeric FHN subunit glycoprotein
1 Cancer and Infectious Disease Research and 2 Molecular Biology Research, The Upjohn Company, 301 Henrietta Street, Kalamazoo, Michigan 49001, U.S.A. 49001 A cotton rat model of experimental human parainfluenza virus type 3 (PIV-3) infection was used to examine the efficacy of FHN, a novel chimeric...
Saved in:
Published in | Journal of general virology Vol. 74; no. 3; pp. 471 - 477 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Reading
Soc General Microbiol
01.03.1993
Society for General Microbiology |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | 1 Cancer and Infectious Disease Research
and 2 Molecular Biology Research, The Upjohn Company, 301 Henrietta Street, Kalamazoo, Michigan 49001, U.S.A. 49001
A cotton rat model of experimental human parainfluenza virus type 3 (PIV-3) infection was used to examine the efficacy of FHN, a novel chimeric glycoprotein which contains the extracellular regions of the fusion (F) and haemagglutininneuraminidase (HN) glycoproteins of PIV-3. The FHN protein was expressed in insect cells using a baculovirus vector system. FHN vaccination resulted in induction of neutralizing antibodies, was completely protective at doses of 100 ng, and was superior to vaccination with secreted forms F and HN proteins, or mixtures of the F and HN glycoproteins. In addition, FHN immunization induced lymphoproliferative responses in mice which were directed against both the F and HN glycoproteins. Fusion of the F and HN proteins into a single chimeric glycoprotein appeared to enhance the protective immune response compared to that elicited by the individual glycoproteins or mixtures of the two glycoproteins.
Received 14 July 1992;
accepted 19 October 1992. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
ISSN: | 0022-1317 1465-2099 |
DOI: | 10.1099/0022-1317-74-3-471 |